Skip to main content
. 2021 Feb 18;2021:8836117. doi: 10.1155/2021/8836117

Table 2.

Analysis of IL-6, IL-8, and TNF-α levels after treatment.

Outcomes Number of included studies Heterogeneity Effect model SMD (95%CI) P
P I 2 (%)
IL-6 3 0.49 0 Fixed-effects model −1.61 [−1.91, −1.30] <0.00001
IL-8 3 0.31 13 Fixed-effects model −1.68 [−1.99, −1.38] <0.00001
TNF-α 3 0.59 0 Fixed-effects model −1.68 [−1.98, −1.37] <0.00001